(Reuters) – Europe’s drug regulator has found a possible link between rare heart infections and COVID-19 vaccines from Pfizer and Moderna and advised people with a history of rare blood disease to avoid getting J & J’s coronavirus shot.
Cardiac condition myocarditis and pericarditis should be listed as possible side effects of the two mRNA vaccines, the European Medicines Agency (EMA) safety committee said on Friday.
Such cases occurred primarily within 14 days of vaccination, more often after the second dose and in younger adult men, the EMA said. This is in line with the findings of US health officials last month.
The EMA panel also recommended that people with a history of capillary leakage syndrome (CLS) should not be vaccinated with J & J̵
Both AstraZeneca and J&J vaccines use different versions of a cold virus to provide instructions for producing coronavirus proteins to elicit an immune response.
(Reporting by Pushkala Aripaka in Bengaluru; editing by Arun Koyyur)